Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Application (Infectious Diseases, Blood Screening, Research), Products (Instruments, Reagents), End-User (Hospital, Reference Laboratories, Other) - Global Forecast to 2018

The isothermal nucleic acid amplification technology (INAAT) market is poised to reach $1,651 million by 2018 at a CAGR of 13.5% during the forecast period. Though PCR technology dominates the nucleic acid amplification technology market currently, adoption of INAAT technology is expected to be significant in coming years as it offers better clinical results in detecting pathogens during point-of-care testing.
Amongst different products, reagent segment is expected to grow at a faster growth due to its increasing demand in reliable, specific and faster detection of chronic diseases and genetic disorders. On the other hand, infectious disease was found to be the highest revenue generating application segment of isothermal nucleic acid amplification technology (INAAT) market in 2013; it is also expected to grow at higher CAGR of 14.4% during the forecast period due to increasing prevalence of various infectious diseases such as HIV and hepatitis A & B and increasing adoption of INAAT in advanced detection of pathogens globally. Amongst different end-users, adoption of INAAT technologies in reference laboratories is expected to be significant due to increasing importance of advanced technologies in different complex molecular testing.
North America commanded the largest market share of about 44% in 2013; whereas, Asian INAAT market is expected to witness the highest CAGR. High prevalence rate of infectious diseases and significant adoption of novel technologies are the major driving factors in the Asian INAAT market. Leading players in the global INAAT market are also expected to address the unmet needs in emerging nations such as India, China, South Africa, Singapore, and Middle East among others.
The grey area, while estimating the market size, includes the overlapping nature of the applications. The application segment included infectious diseases, blood screening, genetics, oncology, research. It was difficult to evaluate the appropriate applications of INAAT; these were later clarified with the help of various experts that participated during the study. Technology market is not estimated as these are proprietary technologies of leading companies. However, qualitative information such as technology evolution, value chain analysis, comparative analysis of various proprietary technologies, and technology roadmap are incorporated in the research study.
The notable players in the global isothermal nucleic acid amplification technology market include Alere, Inc. (U.S.), Becton, Dickinson & Company (U.S.), BioHelix (U.S.), bioMerieux (France), Hologic Gene-Probe (U.S.), and QIAGEN (The Netherlands).
The extensive market study covers a detailed coverage of market momentum, an in-depth analysis of various influencing factors as well as a comprehensive snapshot of competitive landscape. Such all-inclusive research would help market players to identify growth potential of different sub-segments and formulate a suitable strategy to enter various related industries with the best portfolio.

Table Of Content

1 Introduction
1.1 Objectives Of The Study
1.2 Report Scope
1.3 Research Methodology
1.4 Key Data From Secondary & Primary Sources

2 Executive Summary

3 Technology Landscape Analysis
3.1 Technology Overview
3.2 INAAT Vs. Conventional Methods – Competitive Advantages
3.3 Technology Value Chain Analysis
3.4 Technology Capability and Maturity
3.5 Test Results General Nat Vs. INAAT Poct
3.6 Comparative Analysis Of INAAT Types

4 Technology Investment Potential
4.1 Investment Climate Assessment
4.1.1 Investor Network
4.1.1.1 Investment Climate Assessment
4.1.1.2 Philanthropic Bodies
4.1.1.3 Private Investors & Venture Capital Firms
4.1.1.4 Insights on Current and Future Technology Investment Trends
4.1.1.5 Some Of The Funds and Investments on INAAT
4.2 Evaluation Of Technologies Available For Licensing & Acquisition For Stakeholders
4.3 Analysis Of Potential Application Areas For Technology Investment Using Ose Grid
4.3.1 Ose - Parameters For Evaluation

5 Market Landscape Analysis
5.1 Market Segmentation
5.2 Market Share in Molecular Diagnostics (Mdx)
5.3 Market Dynamics
5.3.1 Drivers – Description
5.3.2 Restraints – Description
5.3.3 Challenges – Description
5.4 Demand-Side Analysis

6 Product Market
6.1 Product/Technology Innovations – Applications
6.1.1 Product/Technology Innovations – Applications
6.1.1.1 INAAT Instrument Market – By Geography
6.1.1.2 INAAT Reagent Market – By Geography

7 Applications Market
7.1 INAAT & Molecular Diagnostics
7.2 Infectious Disease Diagnostics
7.3 Blood Screening
7.4 Laboratory Research
7.5 Cancer Research
7.6 Global INAAT Market – By Application (2013–2018)
7.6.1 INAAT Infectious Diseases Market, By Geography
7.6.2 INAAT Blood Screening Market – By Geography
7.6.3 INAAT Research Market – By Geography

8 End-User Market
8.1 Global Isothermal Nucleic Acid Amplification Technology Market – By End User (2013–2018)
8.2 Global Market – By End User
8.2.1 INAAT Hospitals Market – By Geography
8.2.2 INAAT Reference Laboratories Market – By Geography
8.2.3 INAAT Other End-Users Market – By Geography
8.3 INAAT Market For Hospitals, By Application
8.4 INAAT Market For Reference Laboratories, By Application
8.5 INAAT Market For Other End Users, By Application

9 Geographic Analysis
9.1 Technology Adoption & Development - Key Findings
9.1.1 Global Isothermal Nucleic Acid Amplification Technology Market - By Geography (2013–2018)
9.2 North America
9.2.1 North America – INAAT Market, By Application
9.2.2 North America – Market, By Product
9.2.3 North America – Market, By End User
9.3 Europe
9.3.1 Europe – INAAT Market, By Application
9.3.2 Europe – Market, By Product
9.3.3 Europe – Market, By End User
9.4 Asia
9.4.1 Asia – INAAT Market, By Application
9.4.2 Asia – Market, By Product
9.4.3 Asia – Market, By End User
9.5 Rest Of The World (ROW)
9.5.1 ROW– INAAT Market, By Application
9.5.2 ROW– Market, By Product
9.5.3 ROW– Market, By End User
9.6 Regions With High Technology Adoption

10 Competitive Landscape
10.1 Partnerships, Collaborations & Agreements
10.2 New Product Launches
10.3 Mergers and Acquisitions

11 Company Profiles
11.1 Alere
11.2 Becton, Dickinson and Company (Bd)
11.3 Biohelix
11.4 Biomerieux
11.5 Eiken Chemical Co., Ltd.
11.6 Hologic Gen-Probe
11.7 Lucigen
11.8 Meridian Bioscience, Inc.
11.9 New England Biolabs
11.10 Novartis Diagnostics
11.11 Nugen
11.12 Qiagen
11.13 Ustar Biotechnologies (Hangzhou) Ltd.